Filing Details
- Accession Number:
- 0000950170-24-018045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-21 17:00:25
- Reporting Period:
- 2024-02-13
- Accepted Time:
- 2024-02-21 17:00:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1936258 | Newamsterdam Pharma Co N.v. | NAMS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238401 | G Louis Lange | C/O Newamsterdam Pharma Company N.v. Gooimeer 2-35 Naarden P7 1411 DC | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2024-02-13 | 5,000 | $19.00 | 24,878 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Footnotes
- Represents ordinary shares acquired from the Company in an underwritten public offering. The ordinary shares acquired from the Company were placed into and are being held in a trust account for the benefit of the Reporting Person.
Billionaire Hedge Funds
